Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)

ERJ OPEN RESEARCH

EUROPEAN RESPIRATORY SOC JOURNALS LTD

1. Oxford Respiratory NIHR BRC
2. Wellcome Trust [211050/Z/18/Z]
3. Wellcome Trust [211050/Z/18/Z] Funding Source: Wellcome Trust